Dwar il-kanċer / trattament / drogi / lewkimja
Kontenut
- 1 Drogi Approvati għal-Lewkimja
- 1.1 Drogi Approvati għal Lewkimja Limfoblastika Akuta (KOLLHA)
- 1.2 Kombinazzjonijiet ta 'Droga Użati fil-Lewkimja Limfoblastika Akuta (KOLLHA)
- 1.3 Drogi Approvati għal Lewkimja Mjeloida Akuta (AML)
- 1.4 Kombinazzjonijiet ta 'Drogi Użati fil-Lewkimja Mjeloida Akuta (AML)
- 1.5 Drogi Approvati għan-Neoplażma taċ-Ċellula Dendritika Blast Plasmacytoid (BPDCN)
- 1.6 Drogi Approvati għal Lewkimja Limfoċitika Kronika (CLL)
- 1.7 Kombinazzjonijiet ta 'Droga Użati f'Lewkimja Limfoċitika Kronika (CLL)
- 1.8 Drogi Approvati għal-Lewkimja Meloġenika Kronika (CML)
- 1.9 Drogi Approvati għal Lewkimja taċ-Ċelloli tal-Arblu
- 1.10 Drogi Approvati għal-Lewkimja Meninġea
Drogi Approvati għal-Lewkimja
Din il-paġna telenka mediċini kontra l-kanċer approvati mill-Food and Drug Administration (FDA) għal-lewkimja. Il-lista tinkludi ismijiet ġeneriċi u tad-ditta. Din il-paġna telenka wkoll kombinazzjonijiet ta 'mediċini komuni użati fil-lewkimja. Id-drogi individwali fil-kombinazzjonijiet huma approvati mill-FDA. Madankollu, kombinazzjonijiet ta 'mediċini nfushom ġeneralment mhumiex approvati, iżda jintużaw ħafna.
L-ismijiet tal-mediċini jorbtu mas-sommarji tal-Informazzjoni dwar id-Droga tal-Kanċer tal-NCI Jista 'jkun hemm drogi użati fil-lewkimja li mhumiex elenkati hawn.
Drogi Approvati għal Lewkimja Limfoblastika Akuta (KOLLHA)
Arranon (Nelarabine)
Asparaginase Erwinia chrysanthemi
Asparlas (Calaspargase Pegol-mknl)
Besponsa (Inotuzumab Ozogamicin)
Blinatumomab
Blincyto (Blinatumomab)
Calaspargase Pegol-mknl
Cerubidine (Daunorubicin Hydrochloride)
Clofarabine
Klolari (Clofarabine)
Ċiklofosfamida
Cytarabine
Dasatinib
Daunorubicin Hydrochloride
Dexamethasone
Doxorubicin Hydrochloride
Erwinaze (Asparaginase Erwinia Chrysanthemi)
Gleevec (Imatinib Mesylate)
Iclusig (Ponatinib Hydrochloride)
Inotuzumab Ozogamicin
Imatinib Mesylate
Kymriah (Tisagenlecleucel)
Marqibo (Vincristine Sulfate Liposome)
Mercaptopurine
Methotrexate
Nelarabine
Oncaspar (Pegaspargase)
Pegaspargase
Ponatinib Hydrochloride
Prednisone
Purinethol (Mercaptopurine)
Purixan (Mercaptopurine)
Rubidomycin (Daunorubicin Hydrochloride)
Sprycel (Dasatinib)
Tisagenlecleucel
Trexall (Methotrexate)
Vincristine Sulfate
Vincristine Sulfate Liposome
Kombinazzjonijiet ta 'Droga Użati fil-Lewkimja Limfoblastika Akuta (KOLLHA)
Hyper-CVAD
Drogi Approvati għal Lewkimja Mjeloida Akuta (AML)
Triossidu tal-Arseniku
Cerubidine (Daunorubicin Hydrochloride)
Ċiklofosfamida
Cytarabine
Daunorubicin Hydrochloride
Daunorubicin Hydrochloride u Cytarabine Liposome
Daurismo (Glasdegib Maleate)
Dexamethasone
Doxorubicin Hydrochloride
Enasidenib Mesylate
Gemtuzumab Ozogamicin
Gilteritinib Fumarate
Glasdegib Maleate
Idamycin PFS (Idarubicin Hydrochloride)
Idarubicin Hydrochloride
Idhifa (Enasidenib Mesylate)
Ivosidenib
Midostaurin
Mitoxantrone Hydrochloride
Mylotarg (Gemtuzumab Ozogamicin)
Rubidomycin (Daunorubicin Hydrochloride)
Rydapt (Midostaurin)
Tabloid (Thioguanine)
Thioguanine
Tibsovo (Ivosidenib)
Trisenox (Triossidu Arseniku)
Venclexta (Venetoclax)
Venetoclax
Vincristine Sulfate
Vyxeos (Daunorubicin Hydrochloride u Cytarabine Liposome)
Xospata (Gilteritinib Fumarate)
Kombinazzjonijiet ta 'Drogi Użati fil-Lewkimja Mjeloida Akuta (AML)
ADE
Drogi Approvati għan-Neoplażma taċ-Ċellula Dendritika Blast Plasmacytoid (BPDCN)
- Elzonris (Tagraxofusp-erzs)
- Tagraxofusp-erzs
Drogi Approvati għal Lewkimja Limfoċitika Kronika (CLL)
Alemtuzumab
Arzerra (Ofatumumab)
Bendamustine Hydrochloride
Bendeka (Bendamustine Hydrochloride)
Campath (Alemtuzumab)
Chlorambucil
Copiktra (Duvelisib)
Ċiklofosfamida
Dexamethasone
Duvelisib
Fludarabine Phosphate
Gazyva (Obinutuzumab)
Ibrutinib
Idelalisib
Imbruvica (Ibrutinib)
Leukeran (Chlorambucil)
Mechlorethamine Hydrochloride
Mustargen (Mechlorethamine Hydrochloride)
Obinutuzumab
Ofatumumab
Prednisone
Rituxan (Rituximab)
Rituxan Hycela (Rituximab u Hyaluronidase Human)
Rituximab
Rituximab u Hyaluronidase Human
Treanda (Bendamustine Hydrochloride)
Venclexta (Venetoclax)
Venetoclax
Zydelig (Idelalisib)
Kombinazzjonijiet ta 'Droga Użati f'Lewkimja Limfoċitika Kronika (CLL)
CHLORAMBUCIL-PREDNISONE
CVP
Drogi Approvati għal-Lewkimja Meloġenika Kronika (CML)
Bosulif (Bosutinib)
Bosutinib
Busulfan
Busulfex (Busulfan)
Ċiklofosfamida
Cytarabine
Dasatinib
Dexamethasone
Gleevec (Imatinib Mesylate)
Hydrea (Hydroxyurea)
Hydroxyurea
Iclusig (Ponatinib Hydrochloride)
Imatinib Mesylate
Mechlorethamine Hydrochloride
Mustargen (Mechlorethamine Hydrochloride)
Myleran (Busulfan)
Nilotinib
Omacetaxine Mepesuccinate
Ponatinib Hydrochloride
Sprycel (Dasatinib)
Synribo (Omacetaxine Mepesuccinate)
Tasigna (Nilotinib)
Drogi Approvati għal Lewkimja taċ-Ċellula Xagħar
Cladribine
Intron A (Interferon Rekombinanti Alfa-2b)
Lumoxiti (Moxetumomab Pasudotox-tdfk)
Moxetumomab Pasudotox-tdfk
Interferon Alfa-2b rikombinanti
Drogi Approvati għal Lewkimja taċ-Ċelloli tal-Arblu
Midostaurin
Rydapt (Midostaurin)
Drogi Approvati għal-Lewkimja Meninġea
Cytarabine